Molecular Pathology · 1998 · 24 citations · 41 references
MedicineOncologyPathologyCarcinogenesisGene ExpressionMolecular PathologyBreast PathologyCancer Molecular PathologyDna DamageDna Damage SignalingMalignant NeoplasmsMammary TumorsBreast Cancer Histopathology
The gene mutated in ataxia telangiectasia (ATM) has an established tumour suppressor role in breast cancer. ATM appears to be expressed in most normal cells, including breast epithelium, where it has been postulated to have a nuclear role in cell cycle regulation following DNA damage. However, ATM is not upregulated after DNA damage. In this study, we demonstrate an absence of immunohistologically detectable levels of ATM in the normally quiescent myoepithelial cells that line normal breast ducts. This contrasts dramatically with the significant expression of ATM in the proliferative myoepithelium of sclerosing adenosis (n = 7). This upregulation of ATM suggests that ATM expression is coupled to the proliferative status of the myoepithelium. Our results also indicate that there are factors other than ATM gene mutations that can dramatically influence ATM expression in the breast and that these factors should be considered for their possible implications in carcinogenesis.
41
A Single Ataxia Telangiectasia Gene with a Product Similar to PI-3 Kinase
Kinneret Savitsky, Anat Bar‐Shira, Shlomit Gilad et al. · Science · 1995 · 2.8K citations
Shan‐Rong Shi, Marc E. Key, Krishan L. Kalra · Journal of Histochemistry & Cytochemistry · 1991 · 2.6K citations
Incidence of Cancer in 161 Families Affected by Ataxia–Telangiectasia
Michael Swift, Daphne Morrell, Ruby B. Massey et al. · New England Journal of Medicine · 1991 · 947 citations · Full text
Life Sciences, Genetics, Oncology +14
Antigen unmasking on formalin‐fixed, paraffin‐embedded tissue sections
Giorgio Cattoretti, Stefano Pileri, Carlo Parravicini et al. · The Journal of Pathology · 1993 · 728 citations
Medicine, Immunology, Pathology +11